GoldenGolden
Advanced Search
Exact Sciences (company)

Exact Sciences (company)

Exact Sciences is a Madison, Wisconsin-based biotechnology company focused on developing and manufacturing non-invasive screening tests for the early detection of cancer.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

Funding rounds

People

Name
Role
LinkedIn

Ali Malihi

Investor

Amit Patel

Investor

Andrew Packer

Employee

Antony Salvi

Employee

Ben Frodl

Employee

Camden Moore

Employee

CElda BOrchardt

Employee

Charles Hackworthy

Employee

Dan Donovan

Employee

Douglas Fennig

Employee

Gabriel Lee, PMI-ACP

Investor

Hemanth D. Shenoi, Ph.D.

Employee

Jamison Vaughn

Employee

Jesse Lucas

Employee

Jill Blanchard

Employee

Joshua Haase

Employee

Karen Ostrov

Investor

KATIE SWEENEY

Employee

Lucas Gaffney

Employee

Megan Reiss

Employee

Megan Rothney

Employee

MIchael Matter

Employee

Michael Welch

Employee

Noah Turecek

Employee

Richard Sneider

Employee

Page 1 of 2

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
EXACT SCIENCES CORP
May 24, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following virtual conferences and invited...
EXACT SCIENCES CORP
May 19, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a global leader in cancer diagnostics, today announced new data on its cancer tests and treatment guidance...
EXACT SCIENCES CORP
May 19, 2021
www.prnewswire.com:443
/PRNewswire/ -- The United States Preventive Services Task Force (USPSTF) today released its final colorectal cancer screening recommendation that screening...
Andrew Dunn and Allison DeAngelis
May 10, 2021
Business Insider
The leaders of Regeneron and Guardant Health both saw their 2020 compensation exceed $100 million.
EXACT SCIENCES CORP
May 3, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conferences and invited investors...
April 14, 2021
BioSpace
Exact Sciences Completes Acquisition of Ashion Analytics, LLC, from The Translational Genomics Research Institute, an affiliate of City of Hope - read this article along with other careers information, tips and advice on BioSpace
EXACT SCIENCES CORP
April 14, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its previously announced acquisition of Ashion Analytics, LLC. "As a...
EXACT SCIENCES CORP
April 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its first quarter 2021 financial results after the close...
EXACT SCIENCES CORP
February 22, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following virtual conferences and invited...
EXACT SCIENCES CORP
February 1, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its fourth quarter 2020 financial results after the close...
EXACT SCIENCES CORP
February 1, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conferences and invited investors...
EXACT SCIENCES CORP
January 13, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that it has acquired a worldwide exclusive license to the proprietary TARDIS technology...
EXACT SCIENCES CORP
January 12, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) announced data published today in Cancer Prevention Research, a Journal of the American Association for...
EXACT SCIENCES CORP
January 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $464.5 million and $467.5 million for...
EXACT SCIENCES CORP
December 28, 2020
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors...
Stand Up To Cancer; Unidos Contra El Cáncer
December 17, 2020
www.prnewswire.com:443
/PRNewswire/ -- Today Stand Up To Cancer® (SU2C) unveiled a collaborative initiative aimed at improving colorectal cancer screening, early detection and...
Stand Up To Cancer; Unidos Contra El Cáncer
December 17, 2020
www.prnewswire.com:443
/PRNewswire-HISPANIC PR WIRE/ -- Hoy Unidos Contra El Cáncer® (Stand Up To Cancer, SU2C) dio a conocer una iniciativa de colaboración destinada a mejorar los...
Stand Up To Cancer; Unidos Contra El Cáncer
December 17, 2020
www.prnewswire.com:443
/PRNewswire-HISPANIC PR WIRE/ -- Today Stand Up To Cancer® (SU2C) unveiled a collaborative initiative aimed at improving colorectal cancer screening, early...
EXACT SCIENCES CORP
December 11, 2020
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced the presentation of new data at the virtual 2020 San Antonio Breast Cancer Symposium...
EXACT SCIENCES CORP
November 23, 2020
www.prnewswire.com:443
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conference and invited investors...
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.